ArticleMolecular medicine (Cambridge, Mass.)2025

Preclinical evaluation of candidate "kill or cure" strategies to treat MFN2-related lipodystrophy.

Ineke Luijten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.